Position in CRDF
as of Sep 30, 2026
· filed Oct 2, 2026
Position Value
$831,614
New position
Shares Held
687,285
first reported quarter
Ownership
0.883%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1
of 1 holders
Holding Since
Sep 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Sep 30, 2026GoalVest Advisory LLC holds $931,759 across 10 Biotechnology names. CRDF ranks #1 (89.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRDF |
Cardiff Oncology, Inc.
This page
|
687,285 | $831,614 | |
| 2 | RPRX |
Royalty Pharma plc
|
534 | $31,164 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
27 | $20,473 | |
| 4 | CAPR |
Capricor Therapeutics, Inc.
|
2,100 | $19,887 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
66 | $15,280 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
200 | $6,520 | |
| 7 | IBRX |
ImmunityBio, Inc.
|
500 | $4,720 | |
| 8 | OTLK |
Outlook Therapeutics, Inc.
|
3,000 | $1,720 |
All Filings in CRDF
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-09-30 | $831,614 | 687,285 | Shares | Sole | 2026-10-02 | |
| No filing history on record for this holder in this stock. | ||||||